Home » Topics » BioWorld Science

BioWorld Science
RSS

There's an app for that?!: web-based tool facilitates new antibiotic development

Nov. 27, 2019

Activated NK-92 cell regimens show activity in Merkel cell carcinoma trial

Nov. 27, 2019

La Jolla re-evaluates its development of LJPC-401 due to mixed clinical results

Nov. 27, 2019

FDA approves advancement of Plenitude study with PPP-001

Nov. 27, 2019

Lipids and lupus

Nov. 27, 2019

Less can be more for HIV vaccines, in several ways

Nov. 27, 2019

FDA grants accelerated approval to Oxbryta for sickle cell disease

Nov. 26, 2019

Enrollment underway in ImmunoGen's phase I/II study of IMGN-632 in AML

Nov. 26, 2019

Poxel reports topline data from TIMES 3 open-label extension of imeglimin in type 2 diabetes

Nov. 26, 2019

ACADIA reports phase II topline results on pimavanserin for negative symptoms of schizophrenia

Nov. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...